PUBLISHER: IMARC | PRODUCT CODE: 1379042
PUBLISHER: IMARC | PRODUCT CODE: 1379042
The global clinical laboratory services market size reached US$ 231.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 322.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.7% during 2022-2028.
A clinical laboratory plays an integral role in the healthcare system of an economy as it provides a wide range of services, including the diagnosis, prevention, treatment, and management of patients. These services help healthcare professionals in medical decision-making and personalizing medicines based on the individuals' needs and illness. Clinical laboratory services rely on technologically advanced devices and testing kits to reduce human error and provide reliable results. At present, several clinics are increasingly utilizing software programs and computers to help patients get information about reporting results and billing for completed tests.
The increasing incidence of chronic diseases, such as cancer and diabetes, along with the rising awareness about early diagnosis among individuals, represents one of the major factors contributing to the market growth. Moreover, there is an increase in the introduction of innovative products, such as companion diagnostics, biochips, and microarrays, which is influencing the growth of the market. Apart from this, the increasing cases of coronavirus disease (COVID-19) worldwide are bolstering the need for healthcare resources like clinical laboratories for diagnostics and management of the infection. In line with this, several clinical laboratories are collaborating with hospital facilities to minimize time, cost and human resources and meet the global demand for diagnostic testing. Furthermore, several companies are offering point-of-care (POC) and rapid testing kits to achieve quick results in real-time accurately. Besides this, a significant rise in the number of novel drug candidates in clinical trials is anticipated to drive the demand for clinical laboratory services.
IMARC Group provides an analysis of the key trends in each sub-segment of the global clinical laboratory services market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on test type, service provider and application.
Human and Tumor Genetics
Clinical Chemistry
Medical Microbiology and Cytology
Others
Hospital-Based Laboratories
Stand-Alone Laboratories
Clinic-Based Laboratories
Bioanalytical and Lab Chemistry Services
Toxicology Testing Services
Cell and Gene Therapy Related Services
Preclinical and Clinical Trial Related Services
Drug Discovery and Development Related Services
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Charles River Laboratories, F. Hoffmann-La Roche Ltd, Illumina Inc., NeoGenomics Laboratories Inc., Quest Diagnostics Incorporated, Siemens Healthcare GmbH (Siemens AG) and Thermo Fisher Scientific Inc.